Fourth quarter Continuing operations: · Sales growth was 27 percent in local currency. Sales amounted to SEK 124 (98) million, corresponding to an increase of 26 percent in SEK. · Operating income (EBIT) amounted to SEK 22 (12) million, corresponding to an operating margin of 18 (12) percent. The quarter was affected by the write-down of intangible assets with regard to Labware to the tune of SEK 9 (-) million. · The comparative figures for 2012 relate to continuing operations, Fertility, unless otherwise stated. · Net income amounted to SEK 15 (0) million, which gave earnings per share of SEK 0.77 (-0.01). · Contract manufacturing of STEEN Solution for Xvivo Perfusion AB terminated. · Increased collaboration with Biolamina AB within the stem-cell area resulted in Vitrolife investing SEK 4 million in Biolamina in a directed share issue. Whole year Continuing operations: · Sales growth was 29 percent in local currency. Sales amounted to SEK 453 (362) million, corresponding to an increase of 25 percent in SEK. · Operating income (EBIT) amounted to SEK 80 (50) million, corresponding to an operating margin of 18 (14) percent. · Net income amounted to SEK 57 (27) million, which gave earnings per share of SEK 2.84 (1.36). · Integration of Cryo Management Ltd, which was acquired at the end of 2012, focusing on sales of Primo Vision. · Acquisition of all the shares in the Danish company HertArt ApS, which has developed the Labware range. After the end of the year · The Board proposes a dividend of SEK 1.00 (0.60). · The Board has, in connection with the close, resolved to increase the operating margin target to 17 percent compared to earlier 15 percent at the same time as the ambition for growth remains at 20 percent. Gothenburg, February 6, 2014 VITROLIFE AB (publ) Thomas Axelsson, CEO Queries should be addressed to: Thomas Axelsson, CEO, tel 46 31 721 80 01 Mikael Engblom, CFO, tel 46 31 721 80 14 Vitrolife is required to publish the information in this press release in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on February 6, 2014 at 08:30 a.m. This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails. ________________________________________________________________________________ _ ________________________________ Vitrolife (http://www.vitrolife.com/en/Corporate/) is an international medical device Group. Vitrolife Fertility (http://www.vitrolife.com/en/Fertility/) product area develops, produces and markets medical devices for assisted reproduction. Work is also carried out to enable the use and handling of stem cells for therapeutic purposes Vitrolife (http://www.vitrolife.com/en/Corporate/) has approximately 240 employees and the company's products are sold in almost 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in USA, Australia, France, Italy, United Kingdom, China, Japan, Hungary and Denmark. The Vitrolife share (http://www.vitrolife.com/en/Corporate/Financial/The-share1/) is listed on NASDAQ OMX Stockholm (http://www.nasdaqomxnordic.com/aktier/shareinformation?Instrument=SSE 1 3469), Small Cap. ________________________________________________________________________________ _ ________________________________ Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail: info@vitrolife.com. Website: www.vitrolife.com/
Report on operations 2013: High growth and improved
Top 10 Most Recent News Articles
Scams vs Identity Theft: Trauma's Dark Impact Revealed
Facing the Dark Reality of Scams and Identity Theft Imagine facing a bleak financial horizon because of scams and identity theft, but the weight on your soul ain't about just numbers. That's what the Identity Theft Resource Center's 2026 Consumer Impact Report brings to light. We're talking about massive mental and emotional whirlwinds, way beyond mere dollars and cents....
Continue Reading
kidSTREAM Museum Welcomes Carina Reeves as New CEO
Carina Reeves Takes the Helm at kidSTREAM You know how it goes—sometimes you need fresh leadership to steer the ship. That's exactly what's happening over at kidSTREAM Children's Museum. They've appointed Carina Reeves as their President and CEO after a nationwide hunt. This ain't just another CEO shuffle; it marks a pivotal moment as kidSTREAM inches closer to its...
Continue Reading
FirstEnergy's New Tech to Bolster Pennsylvania Grid
Electricity Demand Spurs Grid Innovation The winds of change are blowing across Pennsylvania's power grid. FirstEnergy Transmission's (NYSE:FE) subsidiary, Keystone Appalachian Transmission Company (KATCo), is diving into a significant federally funded project to reinforce grid reliability. With electricity demand on an upward trajectory, Pennsylvania and beyond need...
Continue Reading
Infection Control Market Set for Explosive Growth by 2031
Untangling the Surge in Infection Control Demand Lately, it's like every healthcare joint worldwide is scrambling for better infection control. We're talking about a market poised to jump from a whopping USD 58.5 billion in 2026 to USD 80.2 billion by 2031—a tidy 37% uptick. That change, brewing at a 6.5% CAGR, speaks volumes about where the industry's heading. What's...
Continue Reading
Evotec SE to Release Q3 Results: What to Expect
Anticipation Builds Around Evotec's Q3 2026 Results It's that time again when everyone's tightening their belts in anticipation of another earnings feed. On November 5, Evotec SE is dropping their results for the first nine months of this whirlwind year. Right out of Germany, Hamburg, they're gearing up for a webcast and conference call where all eyes, or should I say...
Continue Reading
Ryde Group Faces Class Action: Key Investor Takeaways
Ryde Group's Tumble: More Than Just Market Volatility When RYDE shares nosedived like a lead balloon, it wasn't due to a market hiccup—it was a darn mess fueled by alleged manipulation. At the heart of this crash are accusations of a blatant pump-and-dump scheme that allegedly swindled investors out of millions. Pump-and-Dump: The Dirty Mechanics This ain't your regular...
Continue Reading
Life Time's Q3 2026 Results Highlight Solid Growth
Life Time Rolls On With Strong Q3 Performance Sometimes the market hands you pure gold, and that's what Life Time (NYSE: LTH) has right now. They didn't just have a decent quarter; they outright nailed it with a $893.5 million total revenue haul—a hefty 14.2% rise from the prior year. What's driving this ship? Solid growth in membership dues and dynamic personal...
Continue Reading
AskGamblers Unveils Tool for Casino Complaints
A Fresh Move in the Casino World AskGamblers has made a move that might just change the game for online bettors. They’ve rolled out a new casino complaints dashboard designed to revolutionize how players raise issues with casinos. Sure, the gambling world is no stranger to complaints, and it's about time someone in the sector paid attention to airing dirty laundry in a...
Continue Reading
Smirnoff Launches Marvel Event with $12.99 Offer
Smirnoff's Bold Move to Ride Marvel's Coattails Here we are, watching a vodka brand hitch its wagon to a Hollywood juggernaut. Smirnoff has announced a fan experience to toast Marvel Studios' "Avengers: Doomsday." Of course, this isn't just about clinking glasses; it's a marketing stunt dressed in superhero tights. The impressive part? They’re selling the razzmatazz for...
Continue Reading
SELCO and Numerica Unite: A Merger That's All Heart
Big Merger in Credit Union World: SELCO and Numerica Sometimes, it ain't all about dollars and cents. That's the vibe I'm picking up from this merger of equals between SELCO Community and Numerica Credit Unions. This isn't a Wall Street hustle, it's hometown hustle—where the biggest reward isn't just a fat line at the bottom but seeing your community thrive. The Vision...
Continue Reading
